New protein-based nano-switches could lead to faster, more accurate diagnostic tests

FHS
July 27, 2023
5:54 pm

QUT researchers have developed a new approach for designing molecular ON-OFF switches based on proteins which can be used in a multitude of biotechnological, biomedical and bioengineering applications.

Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry “Alliance for RTU” – Biotech Investments

EQS-News: Gerresheimer AG / Key word(s): Alliance Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry “Alliance for RTU” 26.09.2024 / 12:30 CET/CEST The issuer

September 27, 2024

FDA approves Madrigal’s NASH drug, marking the first-ever treatment for the liver disease

Madrigal Pharmaceuticals’ NASH drug won an accelerated approval on Thursday, becoming the first treatment for a liver disease that for years has vexed scientists and

March 15, 2024

Apogee and Spyre founder launches another autoimmune biotech, and it’s got $80M to start

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.